中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2008年
7期
513-515
,共3页
肖玮%王天龙%张联峰%姚兰%徐惠青%杨拔贤
肖瑋%王天龍%張聯峰%姚蘭%徐惠青%楊拔賢
초위%왕천룡%장련봉%요란%서혜청%양발현
肝移植%电解质%炎性因子%血乳酸%心肺功能
肝移植%電解質%炎性因子%血乳痠%心肺功能
간이식%전해질%염성인자%혈유산%심폐공능
Liver transplantation%Electrolytes%Inflammatory cytokines%Lactate%Cardiopulmonary function
目的 研究肝移植术中再灌注前放血的临床意义.方法 32例肝病患者在静脉及吸入复合全麻下行无转流原位肝移植术,分为再灌注前放血组(经门静脉放血200 ml,21例)和对照组(11例).常规麻醉监测,并放置Swan-Ganz导管监测心输出量,无肝前期、无肝期给予抑肽酶、去甲肾上腺素及多巴胺,维持无肝期平均动脉压>70 mm Hg,心输出量指数>2.5 L·min-1·m-2.分别于门静脉阻断即刻(T1)、门静脉开放即刻(T2)、新肝期10min(T3)、新肝期30min(T4)采集桡动脉血液测定电解质、血气及炎性细胞因子浓度(肿瘤坏死因子tumor necrosis factor alpha-alpha,TNF-α;白介素6,Interleukin-6,IL-6).各时间点分别记录心肺功能参数.结果 两组患者心律失常发生率(X2=1.73,P>0.05)和死亡率(X2=1.12,P>0.05)没有显著差别;各时间点血钙、血镁浓度均明显低于正常值;两组患者桡动脉血钾、TNF-α、IL-6均无显著变化,再灌注前放血对乳酸的增长没有影响;各时间点肺氧合功能、心功能参数无显著变化,组间无明显差异.新肝期30 min,两组患者均表现为乳酸、炎性因子呈增高趋势,外周血管阻力指数(systemic vascular resistance index,SVRI)显著下降.结论 再灌注前放血似乎对内环境、心肺功能影响较小.
目的 研究肝移植術中再灌註前放血的臨床意義.方法 32例肝病患者在靜脈及吸入複閤全痳下行無轉流原位肝移植術,分為再灌註前放血組(經門靜脈放血200 ml,21例)和對照組(11例).常規痳醉鑑測,併放置Swan-Ganz導管鑑測心輸齣量,無肝前期、無肝期給予抑肽酶、去甲腎上腺素及多巴胺,維持無肝期平均動脈壓>70 mm Hg,心輸齣量指數>2.5 L·min-1·m-2.分彆于門靜脈阻斷即刻(T1)、門靜脈開放即刻(T2)、新肝期10min(T3)、新肝期30min(T4)採集橈動脈血液測定電解質、血氣及炎性細胞因子濃度(腫瘤壞死因子tumor necrosis factor alpha-alpha,TNF-α;白介素6,Interleukin-6,IL-6).各時間點分彆記錄心肺功能參數.結果 兩組患者心律失常髮生率(X2=1.73,P>0.05)和死亡率(X2=1.12,P>0.05)沒有顯著差彆;各時間點血鈣、血鎂濃度均明顯低于正常值;兩組患者橈動脈血鉀、TNF-α、IL-6均無顯著變化,再灌註前放血對乳痠的增長沒有影響;各時間點肺氧閤功能、心功能參數無顯著變化,組間無明顯差異.新肝期30 min,兩組患者均錶現為乳痠、炎性因子呈增高趨勢,外週血管阻力指數(systemic vascular resistance index,SVRI)顯著下降.結論 再灌註前放血似乎對內環境、心肺功能影響較小.
목적 연구간이식술중재관주전방혈적림상의의.방법 32례간병환자재정맥급흡입복합전마하행무전류원위간이식술,분위재관주전방혈조(경문정맥방혈200 ml,21례)화대조조(11례).상규마취감측,병방치Swan-Ganz도관감측심수출량,무간전기、무간기급여억태매、거갑신상선소급다파알,유지무간기평균동맥압>70 mm Hg,심수출량지수>2.5 L·min-1·m-2.분별우문정맥조단즉각(T1)、문정맥개방즉각(T2)、신간기10min(T3)、신간기30min(T4)채집뇨동맥혈액측정전해질、혈기급염성세포인자농도(종류배사인자tumor necrosis factor alpha-alpha,TNF-α;백개소6,Interleukin-6,IL-6).각시간점분별기록심폐공능삼수.결과 량조환자심률실상발생솔(X2=1.73,P>0.05)화사망솔(X2=1.12,P>0.05)몰유현저차별;각시간점혈개、혈미농도균명현저우정상치;량조환자뇨동맥혈갑、TNF-α、IL-6균무현저변화,재관주전방혈대유산적증장몰유영향;각시간점폐양합공능、심공능삼수무현저변화,조간무명현차이.신간기30 min,량조환자균표현위유산、염성인자정증고추세,외주혈관조력지수(systemic vascular resistance index,SVRI)현저하강.결론 재관주전방혈사호대내배경、심폐공능영향교소.
Objective To investigate the clinical implications of portal vein bloodletting immediately before reperfusion during orthotopic liver transplantation(OLT).Methods Thirty-two patients with end-stage liver diseases undergoing non veno-venous OLT were divided into bloodletting group (n=21)and control group(n=11).During anhepatic phase,we maintained mean arterial pressure >70 mm Hg,cardiac index>2.5 L·min-1·m-2 by infusion,norepinephrine and dopamine.Blood samples were taken at the time when portal vein was clamped(T1),the time when portal vein was unclamped (T2),10 minutes after neohepatic phase(T3),neohepatic phase 30 minutes(T4)for electrolytes,blood gas and plasma inflammatory cytokines.Hemodynamic and ventilation parameters were also recorded.Results There was no significant difference in mortality(X2=1.12,P>0.05)and arrhythmia incidence (X2=1.73,P>0.05)between the two groups.Serum calcium,magnesium were both significantly lower than normal.After anhepatic phase,potassium,tumor necrosis factor alpha,interleukin-6 in radial artery didn't alter significantly;Bloodletting had no effect on lactic acid.There was no significant difference in hemodynamic and ventilation parameters among four time periods.Conclusion Bloodletting seemed to have no effect on changes of internal environment.